NovX21 Inc. (TSXV:NOV), formerly known as Ressources Minières Pro-Or Inc. (TSXV:POI), announced a private placement of 500 units at a price of CAD 4,600 per unit for gross proceeds of CAD 2,300,000 on July 10, 2013. Each unit consists of 20,000 class A shares at a price of CAD 0.23 per share and 20,000 warrants. Each warrant entitles the holder to purchase Class A shares of the company at an exercise price of CAD 0.35 per share for a period of 12 months from the date of issuance. The company will not pay any finders' fee for the transaction. The transaction will include participation from accredited investors. The securities being issued in the transaction is subject to a hold period of four months. The warrants will be subject to an accelerator clause by which the warrant expiry date can be shortened at the corporation's discretion if the closing share price on the exchange is CAD 0.50 or higher for a period of more than 20 consecutive trading days, in which case the new expiry date would be the thirtieth day following formal written notification by the corporation. The transaction is subject to approval by the TSX Venture Exchange and the shareholders of the corporation.

On September 24, 2013, the company amended the terms of the transaction. The transaction will now be a brokered deal. The company will receive gross proceeds of CAD 2,295,000 by issuing 15,300,000 units at CAD 0.15 per unit. Each unit consists of one class A share and one share purchase warrant. The warrants being issued in the transaction will be exercisable at a price of CAD 0.30 per share for a period of 36 months from issuance. Euro Pacific Canada Inc. will act as lead placement agent to the company. The company will pay a cash commission of 8% of the proceeds and issue warrants equal to 8% of the number of units issued in this transaction to the agent. The agent warrants will have an exercise price of CAD 0.30 for a period of 18 months from issuance. The warrants are subject to accelerated expiry, if the closing share price on the exchange is CAD 0.40 or higher for a period of more than 20 consecutive trading days, in which case the new expiry date would be the 30th day following formal written notification by the company.

On December 5, 2013, the company announced that it has amended the terms of the transaction. The company will now issue minimum of 5,000,000 and up to 19,125,000 common shares at CAD 0.12 per share for gross proceeds of CAD 600,000 and up to CAD 2,295,000. Each common share will be accompanied by warrants. Each warrant will entitle the holder to acquire one common share at CAD 0.20 per share for a period of 36 months from the date of issuance. Cash commission payable on orders pursuant to the president list orders shall be 4%. The warrants will be subject to an acceleration clause by which the warrant period of the warrants can be reduced, at the company's discretion, if the closing price of the common shares on the Exchange is equal to or above CAD 0.30 on 20 consecutive trading days, in which case the exercise period of the warrants will be reduced to 30 days following formal written notification by the company to that effect. The securities to be issued are subject to a hold period of four months and one day from the date of distribution. The company will issue broker warrants to the agent, exercisable for a period of 18 months following the closing date, to acquire common shares which in aggregate is equal to 8% of the number of common shares sold in the transaction. The transaction is expected to close on or prior to December 30, 2013.

On December 23, 2013, the company amended the terms of the transaction. The company will now issue 30,000,000 units at CAD 0.10 per unit for gross proceeds of CAD 3,000,000. The company will issue minimum of 6,000,000 units. Each unit consists of one common share and one common share purchase warrant. The transaction will involve the participation of qualified investors, new investors, directors, and management of the company. The broker warrants will be exercisable at CAD 0.10 per share. The transaction is expected to close by December 30, 2013. The first tranche will be concluded in the coming days and the second and final tranche will be closed by December 30, 2013.

On December 27, 2013, the company announced that it has closed the first tranche of the transaction. The company issued 8,000,000 units for gross proceeds of CAD 800,000.

On January 8, 2014, the company announced that it has closed the second tranche of the transaction. The company issued 12,000,000 units for gross proceeds of CAD 1,200,000. The second tranche brings the total amount raised to date to CAD 2,000,000 in the transaction.

On January 21, 2014, NovX21 Inc. closed the transaction. The company issued 29,917,500 units for gross proceeds of CAD 2,991,750. The transaction included participation from 66 investors including, Jean-Paul Schaack for 100,000 units, Sylvain Boulanger, Chief Executive Office